Literature DB >> 7373863

Effects of verapamil and its optical isomers on repetitive slow responses induced by electrical depolarization in canine ventricular myocardium.

T Saikawa, M Arita.   

Abstract

The electrophysiological effects of verapamil (racemic compounds) and its optical (d- and 1-) isomers on canine ventricular myocardial fibers were investigated in current clamp conditions using single sucrose gap chamber and microelectrodes. The current-voltage (I-V) relationships were obtained in normal and low Na (12 mM)--low Ca (0.45 mM) solutions with and without the drugs. Verapamil and its optical isomers blocked repetitive action potential discharges (slow responses) induced by depolarizing DC-currents. However, l-isomer was more potent than d-isomer in suppressing these responses. The difference in the potency was attributed to their different actions on the steady state I-V relationships. Namely, l-isomer increased time independent membrane conductance to potassium ions (probably gk1), while d-isomer did not. This effect of l-isomer may favor the suppression of phase 4 depolarization and hence reduce the frequency of repetitive action potential discharges in depolarized ventricular muscle more effectively than d-isomer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373863     DOI: 10.1536/ihj.21.247

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

Review 1.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

2.  Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.

Authors:  M Eichelbaum; G Mikus; B Vogelgesang
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

3.  Verapamil disposition--effects of sulphinpyrazone and cimetidine.

Authors:  L M Wing; J O Miners; K J Lillywhite
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.